Yu, J., Yu, J., Yu, J., Deng, J., Deng, J., Deng, J., . . . Gong, Y. A high content clonogenic survival drug screening identifies maytansine as a potent radiosensitizer for meningiomas. Frontiers Media S.A.
Chicago Style (17th ed.) CitationYu, Jinxiu, et al. A High Content Clonogenic Survival Drug Screening Identifies Maytansine as a Potent Radiosensitizer for Meningiomas. Frontiers Media S.A.
MLA (9th ed.) CitationYu, Jinxiu, et al. A High Content Clonogenic Survival Drug Screening Identifies Maytansine as a Potent Radiosensitizer for Meningiomas. Frontiers Media S.A.
Warning: These citations may not always be 100% accurate.